Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs HCA Health Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.03 (market cap $29.60B), while HCA Health Inc trades at $411 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 3× Alnylam Pharmaceuticals, Inc.'s market cap, and HCA Health Inc pays a 0.76% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | HCA | |
|---|---|---|
Market Cap | $29.60B | $89.08B |
Sector | Health | Health |
52-Week High | $491.22 | $545.13 |
52-Week Low | $205.48 | $361.32 |
Enterprise Value | $27.56B | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
